Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06394986
Other study ID # ABZ_310518
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 18, 2018
Est. completion date February 18, 2019

Study information

Verified date May 2024
Source Moscow Regional Research and Clinical Institute (MONIKI)
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is a single-arm cohort study aimed to evaluate change of arteriovenous fistula volume blood flow / cardiac output ratio in patients with chronic heart failure (NYHA I-II classes) and with preserved ejection fraction as a result of a hemodialysis session after a "long" interdialysis interval.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date February 18, 2019
Est. primary completion date February 18, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - signed informed consent, - > 18 years - maintenance ("chronic") hemodialysis, - native arteriovenous fistula, - arteriovenous fistula volume blood flow =1 l/min, - arteriovenous fistula volume blood flow / cardiac output ratio < 0.3, - interdialysis weight gain <5% of "dry" body weight, - sufficient hemodialysis dose (eKt/V > 1.2), - chronic heart failure (NYHA I-II classes only), - preserved left ventricular ejection fraction (=50%), - absence of arrhythmias (except first-degree atrioventricular block block), - absence of heart valve disease (except mitral regurgitation grade I-II), - absence of intradialysis hypo/hypertension - "long" interdialysis interval (3 days). Exclusion Criteria: - hypo/hypertension during or after hemodialysis, - arrhythmias (except first-degree atrioventricular block) after hemodialysis.

Study Design


Intervention

Procedure:
Hemodialysis session
Change of arteriovenous fistula volume blood flow / cardiac output ratio in patients with chronic heart failure (NYHA I-II classes) and with preserved ejection fraction as a result of a hemodialysis session will be explored.

Locations

Country Name City State
Russian Federation Moscow Regional Research and Clinical Institute (MONIKI) Moscow

Sponsors (1)

Lead Sponsor Collaborator
Moscow Regional Research and Clinical Institute (MONIKI)

Country where clinical trial is conducted

Russian Federation, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in cardio-fistular recirculation Change in arteriovenous fistula volume blood flow / cardiac output ratio One hour before and two hours after the hemodialysis session.
See also
  Status Clinical Trial Phase
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT05196659 - Collaborative Quality Improvement (C-QIP) Study N/A
Active, not recruiting NCT05896904 - Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction N/A
Completed NCT05077293 - Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
Recruiting NCT05631275 - The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
Enrolling by invitation NCT05564572 - Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology N/A
Enrolling by invitation NCT05009706 - Self-care in Older Frail Persons With Heart Failure Intervention N/A
Recruiting NCT04177199 - What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
Terminated NCT03615469 - Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY) N/A
Recruiting NCT06340048 - Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure Phase 1/Phase 2
Recruiting NCT05679713 - Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
Completed NCT04254328 - The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure N/A
Completed NCT03549169 - Decision Making for the Management the Symptoms in Adults of Heart Failure N/A
Recruiting NCT05572814 - Transform: Teaching, Technology, and Teams N/A
Enrolling by invitation NCT05538611 - Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
Recruiting NCT04262830 - Cancer Therapy Effects on the Heart
Completed NCT06026683 - Conduction System Stimulation to Avoid Left Ventricle Dysfunction N/A
Withdrawn NCT03091998 - Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support Phase 1
Recruiting NCT05564689 - Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy